
Laboratory Corporation of America Holdings LH
€ 218.73
0.43%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Laboratory Corporation of America Holdings Langfristiger Schuldenstrom 2011-2026 | LH
Langfristiger Schuldenstrom Jährlich Laboratory Corporation of America Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 M | 166 M | 164 M | 187 M | - | 206 M | - | - | - | 420 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 420 M | 164 M | 221 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 23.11 | 4.52 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.6 | -0.22 % | $ 2.03 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
838 K | $ 6.1 | 1.16 % | $ 179 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 39.93 | -1.67 % | $ 1.11 B | ||
|
Danaher Corporation
DHR
|
173 M | $ 234.99 | -0.25 % | $ 172 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 12.98 | 6.97 % | $ 368 M | ||
|
DexCom
DXCM
|
21.1 M | $ 68.47 | -2.33 % | $ 26.4 B | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 17.5 | -7.41 % | $ 941 M | ||
|
Celcuity
CELC
|
172 K | $ 105.54 | -3.33 % | $ 4.16 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
29 K | $ 3.4 | 3.66 % | $ 108 K | ||
|
Exact Sciences Corporation
EXAS
|
27.4 M | $ 101.77 | 0.14 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 27.9 | -0.39 % | $ 844 M | ||
|
Guardant Health
GH
|
29.2 M | $ 107.75 | -1.98 % | $ 13.2 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | $ 48.19 | 1.71 % | $ 10.7 B | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
79 M | $ 146.41 | -2.48 % | $ 23.3 B | ||
|
Charles River Laboratories International
CRL
|
54.2 M | $ 214.0 | -1.51 % | $ 11 B | ||
|
IQVIA Holdings
IQV
|
99 M | $ 243.4 | -0.36 % | $ 44.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 177.06 | -0.64 % | $ 19.7 B | ||
|
Biodesix
BDSX
|
719 K | $ 5.77 | -3.27 % | $ 748 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 189.39 | -6.67 % | $ 15.6 B | ||
|
IDEXX Laboratories
IDXX
|
21.5 M | $ 708.9 | -0.79 % | $ 58.5 B | ||
|
Lantheus Holdings
LNTH
|
1.87 M | $ 68.27 | -1.59 % | $ 4.72 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.83 | 1.8 % | $ 6.5 M | ||
|
Bioventus
BVS
|
4.06 M | $ 8.0 | 5.12 % | $ 501 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 29.47 | 1.25 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
218 K | $ 23.85 | 2.49 % | $ 31 M | ||
|
Mettler-Toledo International
MTD
|
29.8 M | $ 1 461.94 | -0.56 % | $ 31 B | ||
|
Myriad Genetics
MYGN
|
12.8 M | $ 6.63 | -0.08 % | $ 601 M | ||
|
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.64 | 1.75 % | $ 2.49 M |